Article

The Boston based synthetic biology startup, Ginkgo Bioworks has raised $100 million dollars of series C investment to pool into …

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

More in Applied Research


Applied Research

Eliminating Single Enzyme from Gut Microbiome May Treat Crohn’s Disease

What is Crohn’s disease? Crohn’s disease is a chronic inflammatory bowel disease of the digestive tract, characterized by inflammation. This ...

Applied Research

Traditional Drug of Amazon Could Help Treat Alcoholism and Depression

A traditional psychedelic drug, Ayahuasca is typically taken a as tea by the people of Amazon region of South America. ...

Applied Research

“Butterfly Child” Hassan Received New Skin After Successful Gene Therapy

A Syrian boy named Hassan famously known as “Butterfly Child” was only few days old when the surface layer of ...

Applied Research

IUDs used for Contraception Quietly Protect against Cervical Cancer

Intrauterine devices (IUDs) provide a strategic and safe option to women against unplanned pregnancy. These tiny, flexible T-shaped devices after ...

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Highlights Herein, we are proposing the seven new healthcare business ideas in India in 2018 which are based on our ...

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.

Leave a reply